Status:
RECRUITING
Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Coronary revascularization, such as heart bypass surgery (CABG) and percutaneous coronary intervention (PCI \[inserting a stent to open up blood vessels\]) improve survival for people with coronary ar...
Detailed Description
Coronary revascularization improves survival for patients with coronary artery disease (CAD). Despite successful coronary revascularization treatment, however, many patients with CAD are left sufferin...
Eligibility Criteria
Inclusion
- patients with coronary artery disease treated with PCI or CABG;
- willing to come onsite for exercise sessions;
- able to perform a cardiopulmonary exercise testing (CPET); and,
- at least 40 years of age.
Exclusion
- currently participating in a CR program;
- unstable angina or established diagnosis of atrial fibrillation, chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy; or,
- unable to return for 10-week follow-up visit.
Key Trial Info
Start Date :
December 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05434117
Start Date
December 9 2022
End Date
April 1 2026
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7